» Articles » PMID: 23589817

Incidence of Childhood and Adolescent Melanoma in the United States: 1973-2009

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2013 Apr 17
PMID 23589817
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Childhood and adolescent melanoma is rare but has been increasing. To gain insight into possible reasons underlying this observation, we analyzed trends in melanoma incidence diagnosed between the ages of 0 and 19 years among US whites by gender, stage, age at diagnosis, and primary site. We also investigated incidence trends by UV-B exposure levels.

Methods: By using Surveillance, Epidemiology, and End Results (SEER) program data (1973-2009), we calculated age-adjusted incidence rates (IRs), annual percent changes, and 95% confidence intervals for each category of interest. Incidence trends were also evaluated by using joinpoint and local regression models. SEER registries were categorized with respect to low or high UV-B radiation exposure.

Results: From 1973 through 2009, 1230 children of white race were diagnosed with malignant melanoma. Overall, pediatric melanoma increased by an average of 2% per year (95% confidence interval, 1.4%-2.7%). Girls, 15- to 19-year-olds, and individuals with low UV-B exposure had significantly higher IRs than boys, younger children, and those living in SEER registries categorized as high UV-B. Over the study period, boys experienced increased IRs for melanoma on the face and trunk, and females on the lower limbs and hip. The only decreased incidence trend we observed was among 15- to 19-year-olds in the high UV-B exposure group from 1985 through 2009. Local regression curves indicated similar patterns.

Conclusions: These results may help elucidate possible risk factors for adolescent melanoma, but additional individual-level studies will be necessary to determine the reasons for increasing incidence trends.

Citing Articles

Illuminating the Connection: Cutaneous Vitamin D Synthesis and Its Role in Skin Cancer Prevention.

Ucar N, Holick M Nutrients. 2025; 17(3).

PMID: 39940244 PMC: 11821240. DOI: 10.3390/nu17030386.


Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review.

Vyas C, Moshyk A, Fusaro G, Zacharoulis S, Fazeli M, Gaind N Melanoma Manag. 2025; 11(1):2382075.

PMID: 39869446 PMC: 11352708. DOI: 10.1080/20450885.2024.2382075.


Recent global patterns in skin cancer incidence, mortality, and prevalence.

Wang M, Gao X, Zhang L Chin Med J (Engl). 2024; 138(2):185-192.

PMID: 39682020 PMC: 11745855. DOI: 10.1097/CM9.0000000000003416.


Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.

Sutthatarn P, Davidoff A, Bahrami A, Richard C, Shalini B, Santiago T Pediatr Surg Int. 2024; 40(1):68.

PMID: 38441654 PMC: 10914839. DOI: 10.1007/s00383-024-05646-8.


Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study.

Du Y, Qi Z, Liang X, Dai J, Wei X, Bai X Dermatol Pract Concept. 2024; 14(1).

PMID: 38364395 PMC: 10868960. DOI: 10.5826/dpc.1401a26.


References
1.
Downing A, Newton-Bishop J, Forman D . Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006; 95(1):91-5. PMC: 2360483. DOI: 10.1038/sj.bjc.6603216. View

2.
Magnanti B, Dorak M, Parker L, Craft A, James P, McNally R . Sex-specific incidence and temporal trends in solid tumours in young people from Northern England, 1968-2005. BMC Cancer. 2008; 8:89. PMC: 2358914. DOI: 10.1186/1471-2407-8-89. View

3.
ROBBINS J, Kraemer K, LUTZNER M, Festoff B, Coon H . Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med. 1974; 80(2):221-48. DOI: 10.7326/0003-4819-80-2-221. View

4.
Linabery A, Ross J . Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 2008; 113(9):2575-96. PMC: 2765225. DOI: 10.1002/cncr.23866. View

5.
Braam K, Overbeek A, Kaspers G, Ronckers C, Schouten-van Meeteren A, van Dulmen-den Broeder E . Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: a systematic review. Pediatr Blood Cancer. 2012; 58(5):665-74. DOI: 10.1002/pbc.24023. View